Laureate Develops Dyax Candidate into Phase I Trials
Dyax says the entry of its human antibody drug candidate DX-2930 into clinical trials is thanks to successful development and up-scale manufacturing by Laureate Biopharma.
Archives for August 26, 2013
Garmen to Make Podophyllotoxin Extract Adva-27a for Sunshine BioPharma
Canadian contract manufacturing and testing firm Garmen Laboratories will be acquired by Cancer drug developer Advanomics Corp in a deal announced today.
Aoxing's Sales Soar After "Capsule Fiasco" Almost Ruined Company
Aoxing Pharmaceuticals reported increased sales and lower operating expenses for Q2 2013 one year on from the chromatin-tainted gelatin scandal that led to suspension of sales by China’s regulators.
Microbial Contamination Leads to Dr. Reddy's Recall
Five lots of a Dr Reddy’s manufactured gastric drug have been recalled due to microbial contamination.
EFPIA Backs MHRA Plan to Inspect APIs at Plants Not Ports
EFPIA has backed MHRA plans to inspect API imports at manufacturing plants rather than at UK borders.
Amarin Asks US FDA to OK Novasep as Vascepa API Supplier
Amarin wants US regulatory approval to add Novasep to the list of APIs suppliers for its fish oil heart pill, Vascepa.